Rocket Pharmaceuticals, Inc.
RCKT
$3.07
$0.082.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.49% | -5.35% | -2.15% | -1.91% | -5.10% |
| Total Depreciation and Amortization | 31.66% | 32.08% | 28.93% | 22.30% | 15.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.04% | 30.51% | 4.91% | 7.16% | 2.36% |
| Change in Net Operating Assets | -95.06% | -94.15% | 396.42% | 488.39% | 414.72% |
| Cash from Operations | -7.44% | -7.60% | 13.30% | 5.35% | 1.15% |
| Capital Expenditure | 72.88% | 64.33% | 31.04% | -24.69% | -64.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 494.55% | 268.53% | 141.56% | 109.27% | 85.78% |
| Cash from Investing | 246.85% | 234.30% | 143.70% | 97.91% | 38.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -3.50% | -10.87% | -98.96% | 23.03% | 10.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.50% | -10.87% | -98.96% | 23.07% | 10.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.64% | 227.36% | -651.84% | 95.46% | 55.62% |